Yi Pei

668 total citations
26 papers, 492 citations indexed

About

Yi Pei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Pei has authored 26 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Yi Pei's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Yi Pei is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Yi Pei collaborates with scholars based in China and United States. Yi Pei's co-authors include Ke Zheng, Shenglong Li, Wei Wang, Xiaojing Zhang, Enduo Qiu, Fei Liu, Guanning Shang, Wei Wang, Shuang Wang and Fei Liu and has published in prestigious journals such as Journal of Clinical Oncology, Life Sciences and Molecular Cancer.

In The Last Decade

Yi Pei

25 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Pei China 12 368 290 71 42 26 26 492
Bing Wei China 15 408 1.1× 283 1.0× 64 0.9× 77 1.8× 55 2.1× 33 622
Yucui Jin China 15 445 1.2× 267 0.9× 76 1.1× 25 0.6× 13 0.5× 30 551
Yameng Cui China 12 490 1.3× 322 1.1× 39 0.5× 27 0.6× 23 0.9× 16 630
Nageswara Rao Dunna India 14 369 1.0× 239 0.8× 81 1.1× 29 0.7× 45 1.7× 34 575
Bhupender Kumar India 15 315 0.9× 173 0.6× 57 0.8× 35 0.8× 30 1.2× 28 490
Sofia La Vecchia Italy 6 210 0.6× 149 0.5× 104 1.5× 50 1.2× 32 1.2× 6 337
Ruyuan Yu China 13 402 1.1× 232 0.8× 72 1.0× 91 2.2× 22 0.8× 20 514
Shun-Fa Yang Taiwan 14 348 0.9× 180 0.6× 112 1.6× 31 0.7× 21 0.8× 21 496
Yanyi Xiao China 14 280 0.8× 121 0.4× 121 1.7× 50 1.2× 41 1.6× 22 457

Countries citing papers authored by Yi Pei

Since Specialization
Citations

This map shows the geographic impact of Yi Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Pei more than expected).

Fields of papers citing papers by Yi Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Pei. The network helps show where Yi Pei may publish in the future.

Co-authorship network of co-authors of Yi Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Pei. A scholar is included among the top collaborators of Yi Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Pei. Yi Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Aili, et al.. (2025). Predictive analysis of all-cause mortality of previously untreated pulmonary tuberculosis patients complicated by hypertension. Frontiers in Cellular and Infection Microbiology. 15. 1574824–1574824.
2.
Pei, Yi, et al.. (2024). Unraveling the impact of noncoding RNAs in osteosarcoma drug resistance: a review of mechanisms and therapeutic implications. International Journal of Surgery. 111(2). 2112–2130. 7 indexed citations
3.
Falchook, Gerald S., Yan Liang, R. Donald Harvey, et al.. (2023). First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3100–3100. 1 indexed citations
4.
Jiang, Shuang, et al.. (2021). Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study. Neuropsychiatric Disease and Treatment. Volume 17. 1579–1587. 4 indexed citations
5.
Li, Shenglong, Fei Liu, Ke Zheng, et al.. (2021). CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Molecular Cancer. 20(1). 161–161. 69 indexed citations
6.
Liu, Fei, Yi Pei, Ke Zheng, et al.. (2020). Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 20(1). 258–258. 37 indexed citations
7.
8.
Pei, Yi, Yueyan Zhang, Ke Zheng, et al.. (2019). <p><em>Ilex hainanensis Merr</em> targets ITGAV to suppress the proliferation and metastasis of osteosarcoma cells</p>. OncoTargets and Therapy. Volume 12. 4499–4507. 10 indexed citations
9.
Li, Shenglong, Xixi Wu, Yi Pei, et al.. (2019). PTHR1 May Be Involved in Progression of Osteosarcoma by Regulating miR-124-3p- AR-Tgfb1i1 , miR-27a-3p- PPARG-Abca1 , and miR-103/590-3p- AXIN2 Axes. DNA and Cell Biology. 38(11). 1323–1337. 12 indexed citations
10.
Li, Shenglong, Xixi Wu, Peng Chen, et al.. (2019). Interferon-α versus interleukin-2 in Chinese patients with malignant melanoma. Anti-Cancer Drugs. 30(4). 402–409. 6 indexed citations
11.
Li, Shenglong, Ke Zheng, Yi Pei, Wei Wang, & Xiaojing Zhang. (2019). Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p. Aging. 11(23). 11609–11623. 37 indexed citations
12.
Li, Shenglong, Yi Pei, Wei Wang, et al.. (2019). Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1. Biomedicine & Pharmacotherapy. 114. 108839–108839. 43 indexed citations
13.
14.
Chen, Peng, Ke Zheng, Wei Wang, et al.. (2018). β-Alanine mediated inhibition of PTHR1suppresses the proliferation, invasion and tumorigenesis in metastatic human osteosarcoma U2OS cells. International Journal of Biological Macromolecules. 111. 1255–1263. 11 indexed citations
15.
Pei, Yi, Ke Zheng, Guanning Shang, et al.. (2018). Therapeutic Effect of Strontium Ranelate on Bone in Chemotherapy-Induced Osteopenic Rats via Increased Bone Volume and Reduced Bone Loss. Biological Trace Element Research. 187(2). 472–481. 3 indexed citations
16.
Wang, Wei, Ke Zheng, Yi Pei, & Xiaojing Zhang. (2017). Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 26(3). 373–384. 11 indexed citations
17.
Wang, Xiaoxia, et al.. (2013). Overexpression of IQGAP1 in human pancreatic cancer. Hepatobiliary & pancreatic diseases international. 12(5). 540–545. 31 indexed citations
18.
Wang, Guangbin, Ming He, Yi Pei, et al.. (2012). Comparison of Effects of Vanadium Absorbed by Coprinus comatus with Those of Inorganic Vanadium on Bone in Streptozotocin-Diabetic Rats. Biological Trace Element Research. 149(3). 391–398. 4 indexed citations
19.
20.
Pei, Yi & Qin Fu. (2010). The Effects of Vanadium (V) Absorbed by Coprinus comatus on Bone in Streptozotocin-induced Diabetic Rats. Biological Trace Element Research. 142(3). 748–759. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bing Wei Breakdown of academic impact, for papers by Yucui Jin Breakdown of academic impact, for papers by Yameng Cui Breakdown of academic impact, for papers by Nageswara Rao Dunna Breakdown of academic impact, for papers by Bhupender Kumar Breakdown of academic impact, for papers by Sofia La Vecchia Breakdown of academic impact, for papers by Ruyuan Yu Breakdown of academic impact, for papers by Shun-Fa Yang Breakdown of academic impact, for papers by Yanyi Xiao
Rankless by CCL
2026